RAM
REGN icon

Resona Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Resona Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Sell
30,289
-1,771
-6% -$1.21M 0.09% 207
2026
Q1 		$24.6M Buy
32,060
+106
+0.3% +$81.2K 0.12% 155
2025
Q4 		$24.7M Sell
31,954
-2,374
-7% -$1.61M 0.12% 152
2025
Q3 		$19.3M Sell
34,328
-5,371
-14% -$3.04M 0.09% 203
2025
Q2 		$20.8M Buy
39,699
+1,263
+3% +$705K 0.1% 188
2025
Q1 		$24.4M Buy
38,436
+1,225
+3% +$843K 0.14% 142
2024
Q4 		$26.5M Sell
37,211
-2,752
-7% -$2.31M 0.16% 123
2024
Q3 		$42M Sell
39,963
-690
-2% -$768K 0.24% 82
2024
Q2 		$42.7M Sell
40,653
-1,032
-2% -$1M 0.26% 78
2024
Q1 		$40.1M Buy
+41,685
New +$39.6M 0.24% 87

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Resona Asset Management's REGN Position: Q2 2026 in Review

Resona Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 5.5% in Q2 2026, selling an estimated $1.21M and leaving 30,289 shares worth $18.9M. The position accounts for 0.09% of the portfolio, ranked #207.

Resona Asset Management first reported a position in REGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $42.7M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Resona Asset Management held 30,289 shares of Regeneron Pharmaceuticals worth $18.9M as of Q2 2026.
  • Resona Asset Management sold 1,771 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.21M.
  • Regeneron Pharmaceuticals made up 0.09% of Resona Asset Management's portfolio in Q2 2026, its #207 holding.
  • Resona Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Resona Asset Management's Regeneron Pharmaceuticals position peaked at $42.7M in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.